Daridorexant, a New Dual Orexin Receptor Antagonist to Treat Insomnia Disorder

Abstract

Daridorexant induced a dose-dependent reduction in wake time after sleep onset in subjects with insomnia disorder (Clinicaltrials.gov NCT02839200). Ann Neurol 2020;87:347-356.